Geneviève Tanguay

At Scale AI, we believe now is the time to take AI out of the lab and into the real world. Where businesses can show not what AI will do, but what AI can do. We accelerate the integration of AI across all industries, scaling large and small organizations along the way. Reshaping business models, enhancing decision making, elevating workforce performance. Unleashing new avenues to embolden your business, the economy and the world, to reach our full potential. Together we form a collective committed to strengthening Canada’s position on a global scale.

MAIN is Québec's first network of business accelerators and incubators

This is the Official page of Sterinova. Sterinova develops, manufactures and distributes high quality ready-to-use products for the Canadian and International markets.

This is the Official page of Sterinova. Sterinova develops, manufactures and distributes high quality ready-to-use products for the Canadian and International markets.

Thank you for your interest in Milestone Pharmaceuticals. While we encourage you to explore opportunities with our company, we urge you to be cautious and wary of recruitment scams in which fraudsters pose as representatives of Milestone Pharma. All current openings are available to view on our Careers page. https://milestonepharmaceuticals.applytojob.com/ Milestone Pharmaceuticals Inc. (Nasdaq: MIST) is a Phase 3 clinical-stage biopharmaceutical company dedicated to developing and commercializing the investigational new drug etripamil for the treatment of cardiovascular indications. Etripamil is a novel, potent and short-acting calcium channel blocker designed by Milestone and being developed as a rapid-onset nasal spray to be administered by the patient to terminate episodes of PSVT as they occur. Milestone is actively recruiting patients for a Phase 3 clinical trial of etripamil for the treatment of PSVT. Milestone plans to initiate a Phase 2 clinical trial in atrial fibrillation, another rapid heart rate condition, and expects to subsequently initiate an additional Phase 2 clinical trial in angina to establish proof-of-concept for the broader use of etripamil.

Thank you for your interest in Milestone Pharmaceuticals. While we encourage you to explore opportunities with our company, we urge you to be cautious and wary of recruitment scams in which fraudsters pose as representatives of Milestone Pharma. All current openings are available to view on our Careers page. https://milestonepharmaceuticals.applytojob.com/ Milestone Pharmaceuticals Inc. (Nasdaq: MIST) is a Phase 3 clinical-stage biopharmaceutical company dedicated to developing and commercializing the investigational new drug etripamil for the treatment of cardiovascular indications. Etripamil is a novel, potent and short-acting calcium channel blocker designed by Milestone and being developed as a rapid-onset nasal spray to be administered by the patient to terminate episodes of PSVT as they occur. Milestone is actively recruiting patients for a Phase 3 clinical trial of etripamil for the treatment of PSVT. Milestone plans to initiate a Phase 2 clinical trial in atrial fibrillation, another rapid heart rate condition, and expects to subsequently initiate an additional Phase 2 clinical trial in angina to establish proof-of-concept for the broader use of etripamil.

Panache Ventures is Canadas most active seed stage venture capital fund. Panache is led by a team of experienced operators, with a strong angel investor track record, years of institutional VC experience and a strong network in Canada, in Silicon Valley and worldwide. The fund has a founders-first philosophy, a commitment to diversity and strategically coinvests with smart angel investors and seed stage funds. If you are going to invest in the best early stage tech startups, better invest with Panache! Panache Ventures est le fonds de capital de risque d’amorçage le plus actif au Canada. Panache est mené par une équipe d’opérateurs d’expérience, anges investisseurs à succès et avec des années d’expérience en capital de risque. L’équipe a un réseau vaste au Canada, dans la Silicon Valley et ailleurs dans le monde. Le fonds a une approche qui favorise les entrepreneurs, privilégie la diversité et co-investit stratégiquement avec les meilleurs anges investisseurs et autres fonds d’amorçage. Si vous voulez investir dans les meilleures jeunes entreprises techno, faites-le avec Panache !

For more than 25 years, GLOBOCAM has been the largest truck dealer network in Quebec. With 9 dealerships, we are proud to offer a complete range of solutions that will exceed your expectations. For all your needs concerning new trucks, used trucks, body shop, parts and service, GLOBOCAM is THE reference of the industry. We offer a wide range of medium and heavy trucks from two of the biggest brands: Freightliner and Western Star. In addition to proposing a great variety of new trucks, we also offer a large selection of used trucks among many brands. Our technicians thoroughly inspect each used truck before it’s posted on our inventory. You thus benefit from an unequalled quality guarantee.

At Scale AI, we believe now is the time to take AI out of the lab and into the real world. Where businesses can show not what AI will do, but what AI can do. We accelerate the integration of AI across all industries, scaling large and small organizations along the way. Reshaping business models, enhancing decision making, elevating workforce performance. Unleashing new avenues to embolden your business, the economy and the world, to reach our full potential. Together we form a collective committed to strengthening Canada’s position on a global scale.

Le Centech est un incubateur de calibre mondial dédié aux entreprises de haute technologie (deeptech) à fort potentiel de croissance. Organisme à but non-lucratif et ouvert à tous, le Centech offre deux programmes d’accompagnement pour startups. Le parcours d’accompagnement au Centech débute avec le programme Accélération sur 12 semaines, puis les plus forts potentiels sont sélectionnés pour la prochaine étape, le programme Propulsion (durée de 24 mois). Le Centech se distingue particulièrement dans les domaines des technologies médicales, du manufacturier, des télécoms et microélectronique et autres objets intelligents. En 2022, le Centech a été reconnu par UBI Global parmi les 10 incubateurs d’entreprises universitaires les plus performants au monde. ---------------- Dedicated to high-tech (deeptech) companies with high growth potential, Centech is a world-class business incubator based in Montreal. Open to all, Centech is a non-profit organization offering two support programs for startups: the Acceleration program (12 weeks), then the strongest potentials are selected to get into the Propulsion program (24 months). Centech performs particularly well in the fields of medical technology, manufacturing, telecoms and microelectronics and other intelligent objects. In 2022, Centech as been recognized as a World Top 10 - University Business Incubator by UBI Global.

Creative Destruction Lab (CDL) is a nonprofit organization that delivers an objectives-based program for massively scalable, seed-stage, science- and technology-based companies. The nine-month program employs an objectives-based mentoring process to enhance the performance of technical founders who learn from the insights of experienced entrepreneurs, with the goal of maximizing equity-value creation. Founded by Professor Ajay Agrawal in 2012 at the University of Toronto’s Rotman School of Management, the program has expanded and now has 11 sites across six countries: Toronto, Vancouver, Calgary, Montreal, Halifax, Paris, Madison, Seattle, Estonia, Berlin, and Melbourne. The program combines 5 elements to help companies transition from science projects to scalable and financeable companies: - An emphasis on objective-setting, helping companies focus on what’s most important to their business - Focused mentorship from experienced entrepreneurs who have founded, led, and sold significant tech companies - Technical advice from world-leading scientists, engineers, and economists - Hands-on support from top business students, who embed within the company to provide business support - Opportunities to raise capital, including angels and VCs from Europe and North America The successful commercialization of cutting-edge science and technology achieved through the program has led to the creation of over CAD $35 billion in equity value.